Zatolmilast
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zatolmilast, covering 2026-01-20 to 2026-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS]) [Phase 2]